Latest Breaking News On - Seriese convertible preferred stock - Page 9 : comparemela.com

Avid Bioservices, Inc. Announces Pricing of $125 Million Offering of Exchangeable Senior Notes March 10, 2021 00:20 ET | Source: Avid Bioservices, Inc Avid Bioservices, Inc Tustin, California, UNITED STATES TUSTIN, Calif., March 10, 2021 (GLOBE NEWSWIRE) Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP) (the “company”), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that its wholly-owned subsidiary, Avid SPV, LLC (the “Issuer”), has priced its sale of $125 million aggregate principal amount of exchangeable senior notes due 2026 (the “notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The issuance and sale of the no

United statesExchange commissionAvid bioservices incAboutavid bioservices incSecurities actSeriese convertible preferred stockAvid bioservicesPrivate securities litigation reform actStephanie diazVida strategic partnersNasdaq cdmoContract manufacturingஒன்றுபட்டது மாநிலங்களில்பரிமாற்றம் தரகுஆர்வமுள்ள உயிர் சேவைகள் இன்க்பத்திரங்கள் நாடகம்